BE849366A - Composition du facteur antihemophilique rapidement solubilisee et procede pour la preparer - Google Patents

Composition du facteur antihemophilique rapidement solubilisee et procede pour la preparer

Info

Publication number
BE849366A
BE849366A BE173226A BE173226A BE849366A BE 849366 A BE849366 A BE 849366A BE 173226 A BE173226 A BE 173226A BE 173226 A BE173226 A BE 173226A BE 849366 A BE849366 A BE 849366A
Authority
BE
Belgium
Prior art keywords
preparing
composition
antihemophilic factor
quickly solubilized
solubilized
Prior art date
Application number
BE173226A
Other languages
English (en)
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of BE849366A publication Critical patent/BE849366A/fr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/14—Blood; Artificial blood
    • A61K35/16—Blood plasma; Blood serum
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/36—Blood coagulation or fibrinolysis factors
    • A61K38/37—Factors VIII
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/19—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles lyophilised, i.e. freeze-dried, solutions or dispersions

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Hematology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Zoology (AREA)
  • Cell Biology (AREA)
  • Immunology (AREA)
  • Dermatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • Developmental Biology & Embryology (AREA)
  • Virology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
BE173226A 1975-12-22 1976-12-13 Composition du facteur antihemophilique rapidement solubilisee et procede pour la preparer BE849366A (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US64317875A 1975-12-22 1975-12-22

Publications (1)

Publication Number Publication Date
BE849366A true BE849366A (fr) 1977-04-01

Family

ID=24579687

Family Applications (1)

Application Number Title Priority Date Filing Date
BE173226A BE849366A (fr) 1975-12-22 1976-12-13 Composition du facteur antihemophilique rapidement solubilisee et procede pour la preparer

Country Status (3)

Country Link
US (1) US4089944A (fr)
BE (1) BE849366A (fr)
SE (1) SE7613775L (fr)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4186192A (en) * 1978-12-18 1980-01-29 Cutter Laboratories, Inc. Stabilized immune serum globulin
EP0035204B2 (fr) * 1980-03-05 1991-05-22 Miles Inc. Compositions pasteurisées de protéines thérapeutiquement actives
JPS5874617A (ja) * 1981-10-28 1983-05-06 Green Cross Corp:The 人由来血液凝固第７因子含有水溶液の加熱処理方法
US4478829A (en) * 1983-04-28 1984-10-23 Armour Pharmaceutical Company Pharmaceutical preparation containing purified fibronectin
FR2613619B1 (fr) * 1987-04-07 1993-10-15 Recherche Informatique Pharmacie Medicaments, produits dietetiques ou produits d'hygiene sous forme de compositions pulverulentes obtenues par adsorption de principes actifs sur un sucre a dissolution rapide
US5605884A (en) * 1987-10-29 1997-02-25 Rhone-Poulenc Rorer Pharmaceuticals Inc. Factor VIII formulations in high ionic strength media
US4877608A (en) * 1987-11-09 1989-10-31 Rorer Pharmaceutical Corporation Pharmaceutical plasma protein formulations in low ionic strength media
US5612320A (en) * 1993-12-22 1997-03-18 Internutria, Inc. Therapeutic carbohydrate blends for treating and aiding premenstrual syndrome
US5595772A (en) * 1995-06-07 1997-01-21 Massachusetts Institute Of Technology Composition and methods for losing weight
US5659017A (en) * 1995-11-07 1997-08-19 Alpha Therapeutic Corporation Anion exchange process for the purification of Factor VIII
DE69733664T3 (de) 1996-04-19 2011-04-14 Grifols Inc. (n.d. Ges.d.Staates Delaware), Los Angeles Verfahren zur INaktivierung von Viren und Lyophilisierung von Blutproteinen
RU2244556C2 (ru) 1999-02-22 2005-01-20 Юниверсити Оф Коннектикут Новые не содержащие альбумин составы фактора viii
US20020077276A1 (en) * 1999-04-27 2002-06-20 Fredeking Terry M. Compositions and methods for treating hemorrhagic virus infections and other disorders
US6962700B1 (en) 2000-09-13 2005-11-08 Atopix Pharmaceuticals Corporation Method of manufacturing immune globulin
US20020146409A1 (en) * 2001-01-30 2002-10-10 Herring Steven W. Methods for stabilizing lyophilized blood proteins
JP5779780B2 (ja) 2008-11-07 2015-09-16 バクスター・インターナショナル・インコーポレイテッドＢａｘｔｅｒ Ｉｎｔｅｒｎａｔｉｏｎａｌ Ｉｎｃｏｒｐ０Ｒａｔｅｄ 第ｖｉｉｉ因子製剤
CA3078625C (fr) 2017-10-09 2023-01-17 Terumo Bct Biotechnologies, Llc Recipient de lyophilisation et son procede d'utilisation
WO2020185916A1 (fr) 2019-03-14 2020-09-17 Terumo Bct Biotechnologies, Llc Agencement de remplissage de contenant de lyophilisation, système et procédé d'utilisation

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2826533A (en) * 1954-03-15 1958-03-11 Cutter Lab Stable fibrinogen solutions and method for producing same
US3057781A (en) * 1956-02-23 1962-10-09 U S Pharmaceutical Inc Stabilization of plasma with invert sugar
US3803115A (en) 1972-05-17 1974-04-09 Baxter Laboratories Inc Stabilization of ahf using heparin
US3973002A (en) * 1974-04-12 1976-08-03 E. R. Squibb & Sons, Inc. Antihemophilic factor

Also Published As

Publication number Publication date
US4089944A (en) 1978-05-16
SE7613775L (sv) 1977-06-23

Similar Documents

Publication Publication Date Title
FR2327763A1 (fr) Composition antisudorifique et procede pour son obtention
BE849366A (fr) Composition du facteur antihemophilique rapidement solubilisee et procede pour la preparer
RO70769A (fr) Procede pour la preparation des derives de 2-phenyle-3-acylbenzothiophene
RO75248A (fr) Procede pour la preparation des derives de quinazoline
RO74936A (fr) Procede pour la preparation des mercaptoazetidiones
FR2325668A1 (fr) Procede pour la preparation de polyurethannes
RO68441A (fr) Procede pour la preparation des derives d'erythromycylamine
BE849416A (fr) Composition anti-moussage pour le traitement de denrees alimentaires
PT65388B (fr) Procede pour la preparation de peptides
RO70768A (fr) Procede pour la preparation des derives de 2-aryle-5-phenylbenzothiophene
PT64912A (fr) Procede pour la preparation de derives de salicilanilide
FR2320300A1 (fr) Procede de preparation de chromanones-(4)
RO75110A (fr) Procede pour la preparation des derives de diphenyleamine
BE842584A (fr) Procede pour la preparation de dihalogenures gemines
RO70079A (fr) Procede pour la preparation des n-aryle-n-(4-pyperidinyle)-arylacetamides
BE844943A (fr) Procede de preparation de chromanones-(4)
PT64718A (fr) Procede pour la preparation de phenyalcoylamines
RO77935A (fr) Procede pour la preparation des cis-4a-arylo tahydro-1h-2-pyrinidine s
FR2275480A1 (fr) Procede pour la preparation de derives d'azetidone-tiazolidine
FR2306976A1 (fr) Procede pour la preparation d'aminoacides
RO72558A (fr) Procede pour la preparation des cycloalcanpyrazoles
FR2317290A1 (fr) Procede pour la preparation de 5-cyanopyridones-(6)
FR2313336A2 (fr) Procede pour la preparation de cycloalcanones et cycloalcanols
RO76124A (fr) Procede pour la preparation des derives de 3-hydroxymethylene-4-chromanone
BE823716A (fr) Procede pour la preparation de derives 17-acylesters de 17 alpha

Legal Events

Date Code Title Description
RE Patent lapsed

Owner name: BAXTER TRAVENOL LABORATORIES INC.

Effective date: 19851231